Jump to Navigation
Drone diving to record level in Malaysian plane search
Surge Energy: 3 Different Insiders Have Purchased Shares...
What Is Wrong With Solar Leases And PPAs And How Can The...
Cranes to help stabilize ferry
Oil slick spotted near sunken ship
TCS net profit now within striking distance of Reliance...
One in 4 Wipro staff to get up to 20% hike
Bodies found trapped inside sunken South Korean ferry
Diageo open offer to USL stake attractive: Analysts
Sony Xperia E1 review: An affordable phone that offers...
BioSante CEO Pleased With LibiGel Progress
Biotech Deal Activity Takes a Breather
Biotech Deals Keep Flowing, From Big Pharma to Industrials
Six Trades on FDA, Clinical Trial Binary Events
Biosante: Key Catalysts Should Renew Investor Interest
15 Biotech Stocks With the Lowest Put/Call Ratios
Amgen, Celgene and Novartis in the Fight Against Pancreatic Cancer
Is BioSante Pharmaceuticals Next in Line to Receive Institutional Praise?
BioSante Attracts Institutional Investors Ahead of Key FDA Catalysts in 2011
Life Sciences Companies Raise Record Amounts of Capital
Two Biotechs Poised for Gains as Call Options Boost Investor Sentiment
Two Small-Cap Biotechs and a Sector ETF to Keep You Afloat During the Market Correction
Top 24 Small Cap Stocks Being Chased by Smart Money
Biosante Pharma Up After FDA Announces Review of Testosterone Gel
Why BioSante Expects a Positive Review of Drug for Female Sexual Disorder
Platform and Specialty Pharmaceutical Companies Could Strengthen in Face of Big Pharma's Patent Cliff
7 Speculative Healthcare Stocks to Rejuvenate Your Portfolio
6 Prime Biotechs for Short and Long-Term Gains
7 Dirt-Cheap Takeover Targets in Biotech
With Cancer Vaccines in Play, Will Investors Continue to Buy-In?
3 Small Cap Biotech Companies With Future Potential
3 Micro Caps With 50% Upside Potential
Upcoming PDUFA Dates for Sub-$5 Stocks
Friday Options Brief: ADM, TRW, RDWR & BPAX
Please Join Us at Our NYC Meetup Next Friday,...
White House Refuses To Comment On Petition To...
Create new account
Request new password
Click on the icon to sign in with your social network login or enter your Bullfax.com login
EUR/GBP: 1.2157 USD/EUR: 1.3813 JPY/USD: 102.425
Bullfax.com - Market News & Analysis 2008-2011
Terms & Conditions